Slideshow

Q&A: Addiction Medicine

In this podcast, Dr Michael Miller, Director of the American Board of Addiction Medicine, discusses addiction medicine, including the new ASAM, patient placement criteria, and DSM-5 changes.

[[{"type":"media","view_mode":"media_crop","fid":"17659","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_9005627882541","media_crop_h":"199","media_crop_image_style":"-1","media_crop_instance":"1051","media_crop_rotate":"0","media_crop_scale_h":"188","media_crop_scale_w":"140","media_crop_w":"148","media_crop_x":"51","media_crop_y":"10","style":"float: right;","title":" ","typeof":"foaf:Image"}}]]There is a new American Society of Addiction Medicine (ASAM) definition of addiction; patient placement criteria are being revised; and DSM-5 has introduced changes regarding addiction.We have asked Michael Miller, MD, to address 3 questions about these issues in this 6-minute podcast:1. The American Society of Addiction Medicine (ASAM) has adopted a new definition of addiction. What is the new definition and what are the implications for treatment?2. The ASAM patient placement criteria are being revised. What can you tell us about the latest revision?3. What are the major changes in DSM-5 regarding addiction that psychiatrists should know about?Dr. Miller is Medical Director of the Herrington Recovery Center at Rogers Memorial Hospital in Oconomowoc, Wisconsin. He is also Director of the American Board of Addiction Medicine and Managing Editor of the ASAM criteria.For more information, please visit this website: www.asamcriteria.org.

Related Videos
brain
nicotine use
© 2024 MJH Life Sciences

All rights reserved.